Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study.

Rafi S, Piduru SM, El-Rayes B, Kauh JS, Kooby DA, Sarmiento JM, Kim HS.

Cardiovasc Intervent Radiol. 2013 Apr;36(2):440-8. doi: 10.1007/s00270-012-0463-4. Epub 2012 Sep 7.

PMID:
22956045
[PubMed - indexed for MEDLINE]
2.

Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.

Mouli S, Memon K, Baker T, Benson AB 3rd, Mulcahy MF, Gupta R, Ryu RK, Salem R, Lewandowski RJ.

J Vasc Interv Radiol. 2013 Aug;24(8):1227-34. doi: 10.1016/j.jvir.2013.02.031. Epub 2013 Apr 19.

PMID:
23602420
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.

Hoffmann RT, Paprottka PM, Schön A, Bamberg F, Haug A, Dürr EM, Rauch B, Trumm CT, Jakobs TF, Helmberger TK, Reiser MF, Kolligs FT.

Cardiovasc Intervent Radiol. 2012 Feb;35(1):105-16. doi: 10.1007/s00270-011-0142-x. Epub 2011 Mar 24.

PMID:
21431970
[PubMed - indexed for MEDLINE]
4.

Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.

Saxena A, Bester L, Chua TC, Chu FC, Morris DL.

Ann Surg Oncol. 2010 Feb;17(2):484-91. doi: 10.1245/s10434-009-0777-x. Epub 2009 Oct 30.

PMID:
19876691
[PubMed - indexed for MEDLINE]
5.

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.

Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, Newman SB, Benson A 3rd, Omary RA, Salem R.

Cancer. 2008 Oct 15;113(8):2119-28. doi: 10.1002/cncr.23818.

PMID:
18759346
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A 3rd, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R.

Radiology. 2008 May;247(2):507-15. doi: 10.1148/radiol.2472062029. Epub 2008 Mar 18.

PMID:
18349311
[PubMed - indexed for MEDLINE]
8.

Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.

Mulcahy MF, Lewandowski RJ, Ibrahim SM, Sato KT, Ryu RK, Atassi B, Newman S, Talamonti M, Omary RA, Benson A 3rd, Salem R.

Cancer. 2009 May 1;115(9):1849-58. doi: 10.1002/cncr.24224.

PMID:
19267416
[PubMed - indexed for MEDLINE]
Free Article
9.

Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.

Saxena A, Kapoor J, Meteling B, Morris DL, Bester L.

Ann Surg Oncol. 2014 Apr;21(4):1296-303. doi: 10.1245/s10434-013-3436-1. Epub 2013 Dec 15.

PMID:
24337647
[PubMed - indexed for MEDLINE]
10.

Radioembolization in patients with hepatic metastases from breast cancer.

Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Reiser MF, Helmberger TK.

J Vasc Interv Radiol. 2008 May;19(5):683-90. doi: 10.1016/j.jvir.2008.01.009. Epub 2008 Mar 19.

PMID:
18440456
[PubMed - indexed for MEDLINE]
11.

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.

Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Gates VL, Atassi B, Newman S, Omary RA, Benson AB 3rd, Salem R.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):887-94. doi: 10.1016/j.ijrobp.2011.07.041. Epub 2011 Dec 2.

PMID:
22137020
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.

Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Atassi B, Baker T, Gates V, Miller FH, Sato KT, Wang E, Gupta R, Benson AB, Newman SB, Omary RA, Abecassis M, Kulik L.

Gastroenterology. 2010 Jan;138(1):52-64. doi: 10.1053/j.gastro.2009.09.006. Epub 2009 Sep 18.

PMID:
19766639
[PubMed - indexed for MEDLINE]
13.

Yttrium-90 radioembolization for the treatment of unresectable hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.

Donahue LA, Kulik L, Baker T, Ganger DR, Gupta R, Memon K, Abecassis MM, Salem R, Lewandowski RJ.

J Vasc Interv Radiol. 2013 Jan;24(1):74-80. doi: 10.1016/j.jvir.2012.09.030.

PMID:
23273699
[PubMed - indexed for MEDLINE]
14.

Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.

Klingenstein A, Haug AR, Zech CJ, Schaller UC.

Cardiovasc Intervent Radiol. 2013 Feb;36(1):158-65. doi: 10.1007/s00270-012-0373-5. Epub 2012 Apr 21.

PMID:
22526099
[PubMed - indexed for MEDLINE]
15.

A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.

Saxena A, Bester L, Shan L, Perera M, Gibbs P, Meteling B, Morris DL.

J Cancer Res Clin Oncol. 2014 Apr;140(4):537-47. doi: 10.1007/s00432-013-1564-4. Epub 2013 Dec 7. Review.

PMID:
24318568
[PubMed - indexed for MEDLINE]
16.

Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases.

Cianni R, Urigo C, Notarianni E, Saltarelli A, Salvatori R, Pasqualini V, Dornbusch T, Cortesi E.

Cardiovasc Intervent Radiol. 2009 Nov;32(6):1179-86. doi: 10.1007/s00270-009-9658-8. Epub 2009 Aug 13.

PMID:
19680720
[PubMed - indexed for MEDLINE]
17.

Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.

Piduru SM, Schuster DM, Barron BJ, Dhanasekaran R, Lawson DH, Kim HS.

J Vasc Interv Radiol. 2012 Jul;23(7):943-8. doi: 10.1016/j.jvir.2012.04.010. Epub 2012 May 19.

PMID:
22609292
[PubMed - indexed for MEDLINE]
18.

18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.

Haug AR, Tiega Donfack BP, Trumm C, Zech CJ, Michl M, Laubender RP, Uebleis C, Bartenstein P, Heinemann V, Hacker M.

J Nucl Med. 2012 Mar;53(3):371-7. doi: 10.2967/jnumed.111.096230. Epub 2012 Feb 13.

PMID:
22331219
[PubMed - indexed for MEDLINE]
Free Article
19.

Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.

Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.

Cancer J. 2006 Mar-Apr;12(2):113-22.

PMID:
16630402
[PubMed - indexed for MEDLINE]
20.

A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma.

D'Avola D, Lñarrairaegui M, Bilbao JI, Martinez-Cuesta A, Alegre F, Herrero JI, Quiroga J, Prieto J, Sangro B.

Hepatogastroenterology. 2009 Nov-Dec;56(96):1683-8.

PMID:
20214218
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk